Do I need licenses in every state I ship peptides to?

There is no universal yes or no here, and any supplier who hands you one is guessing on your behalf. Whether a license, permit, or registration is required in a destination state depends on how that state classifies the material being shipped, how it classifies your business, and whether your activity reads as business-to-business supply of research-use-only materials or as distribution of a drug product to end users. Those are three separate legal questions, and only your attorney and the relevant state agencies can answer them for your specific operation. This article is informational and is not legal advice.

What follows is the mechanism — how the question actually gets resolved rather than what the answer is, which definitions carry the weight, what documentation you should be building regardless of the outcome, and what to demand from a wholesale supplier before any of it becomes your problem.

Why one answer can't cover every jurisdiction

States regulate independently, and they don't use the same vocabulary. One state's licensing framework may be administered by a board of pharmacy, another's by a department of health, a third's by a consumer protection or agriculture agency, and some activities may sit under more than one at once. The categories they license — wholesaler, distributor, manufacturer, repackager, third-party logistics provider, out-of-state or non-resident entity — are defined in each state's own code, and those definitions do not line up neatly across borders.

That's the structural reason a blanket answer is impossible. It also explains a pattern operators run into repeatedly: two businesses doing what looks like the same thing get different answers, because one is handling material a state defines into a regulated category and the other isn't. The variable is almost never the shipping. It's the classification upstream of it.

So the useful work is not searching for a list of states that require a license. It's determining, with counsel, which regulatory buckets your specific activity could fall into, then checking each destination state's treatment of those buckets before you ship there.

The material classification question comes first

Before anyone can tell you whether you need a permit, someone has to establish what you're moving. Research-use-only peptides are supplied as laboratory materials, not as finished drug products, and they are not FDA-approved drugs. They are not intended for human consumption, and nothing about a wholesale purchase changes that framing. Real Peptides supplies compounds on a research-use-only basis, and that designation isn't marketing language — it's the category the material sits in, and it's the starting point for every regulatory conversation downstream.

Why this matters procedurally: many state licensing regimes are written around prescription drugs, devices, or products intended for human or animal use. Whether a given research material falls inside or outside those definitions in a given state is exactly the kind of question you should be putting to counsel — not one to resolve from a forum post or a supplier's reassurance.

Ask the question in the state's own terms. Not "are peptides legal to ship here," which no one can answer cleanly, but "under this state's code, does the material I'm purchasing meet the statutory definition that triggers licensure for my activity?" That's answerable. The vague version isn't.

Then there's how your own business is classified

The second variable is you. A med spa buying research materials for its own use is doing something different from a reseller buying inventory to sell onward, which is different again from a business that repackages, relabels, or holds material for other companies. Each of those activities can be defined differently, and a business that adds a new line — moving from buying to reselling, or from reselling to holding stock for a partner — may move itself into a different regulatory category without ever changing suppliers.

That's a common failure mode worth naming. Operators check compliance once, at launch, then change the shape of the business and never re-check. The check isn't a one-time gate; it's tied to the activity, and the activity evolves.

There's also the question of where your obligations attach. Some frameworks look at where a business is located and licensed. Others look at where the material is going, and use terms like non-resident or out-of-state registration for entities shipping in from elsewhere. Whether any such requirement reaches your activity — and whether the material you handle falls inside the definitions that trigger it — is a question for counsel and the relevant board in each state you intend to serve. Do not assume it works the same way twice.

Where the destination state actually enters the picture

The practical sequence most operators end up following, once they stop searching for a national answer, looks like this.

First, get your own classification settled in your home jurisdiction with an attorney who works in this area. That single determination governs how every other state will read your activity, and it's the cheapest thing you'll ever do to avoid a downstream mess.

Second, build a shipping map. List the states you actually intend to serve — not every state, the ones your business plan touches in the next year. The compliance question is bounded by where you ship, and a shorter list is a faster, cheaper review.

Third, work the list. For each state, the questions are the same: which agency has jurisdiction over this activity, does the definition capture what I'm doing, is there a registration or permit category for out-of-state entities, and what documentation would I need to produce if asked. Counsel can batch this. Guessing at it state by state on your own is how businesses end up with a filing they didn't need and a missing one they did.

Fourth, write down what you learn and date it. Requirements change, agencies reinterpret, and the version of the answer you got is only as good as the day you got it. Re-verify before you enter a new state or change what you're shipping.

Questions to route, and who actually answers them

Most of the confusion in this space comes from sending a question to the wrong party. Suppliers get asked legal questions they can't answer, and attorneys get asked product questions that belong to the supplier. This is how the split generally works.

If a supplier volunteers answers from the left-hand column, that's a signal — not reassurance. Suppliers who tell business buyers they don't need to worry about licensing are making a legal representation they have no standing to make, and it will not help you if a regulator disagrees.

The paperwork trail you control regardless of the answer

Whichever way your licensing question resolves, one thing stays constant: you need to be able to document what you bought, from whom, and what it was. That record is the backbone of any compliance posture, and it's built at the point of purchase or not at all.

At minimum, you want batch-level certificates of analysis tied to the specific lots you received, retained rather than glanced at. You want the testing methodology stated plainly, not summarized. You want invoices and terms that describe the material consistently with how it's actually being supplied. And you want a supplier whose documentation you could hand to a third party without a caveat.

This is where a lot of wholesale relationships quietly fail the test. Practices worth refusing: purity claims with no accompanying analysis; COAs sold as an add-on or produced only on request; test results that can't be traced to a named lab or a stated method; pricing structures opaque enough that you can't reconcile what you paid against what you received. None of those make a supplier illegitimate on their own. All of them make your documentation weaker than it needs to be, at exactly the moment documentation matters.

What Real Peptides does differently

Real Peptides supplies research-use-only compounds at 99%+ HPLC purity, with 6-panel batch testing behind every lot. Those results are published as publicly verifiable COAs — meaning a prospective buyer can check the lab results independently, before opening an account, rather than taking a purity claim on faith or paying to see the underlying data.

Fulfillment is US-based, with orders shipping in 5–7 days. For a buyer managing inventory across a catalog, domestic fulfillment matters for reasons beyond speed: it shortens the chain between the lab result and your shelf, and it keeps the documentation trail intact rather than fragmented across intermediaries.

The Wholesale Partner Program runs on a 3-step application, and pricing tiers are presented rather than negotiated in the dark. What Real Peptides does not do is tell a business buyer whether their operation needs a license in a given state. That determination belongs to your attorney and the relevant state authorities, and a supplier who claims otherwise is overstepping. What a supplier can do is give you verifiable documentation, consistent research-use-only framing, and a paper trail that holds up — and that's the part of the problem worth solving at the supplier level.

Where to go from here

If you've settled your classification with counsel and mapped the states you intend to serve, the remaining decision is which supplier's documentation you want standing behind your catalog. Businesses that can answer the licensing question for their own operation — and want a wholesale relationship with published testing rather than promised testing — are the right fit for the Wholesale Partner Program.

More detail on tiers, minimums, and account setup is available through the wholesale peptides program, and qualified businesses can apply for a wholesale account directly.